Bayer Financial Report Shows That More Than 2,500 Venous / Blood Clot Cases (DVT and/or PE) Do Not Have Settlement Agreements As Of April 15, 2013
(Posted by Tom Lamb at DrugInjuryWatch.com)
From the "Product-related litigations" section of the most recent Bayer Stockholders’ Newsletter -- setting forth the company Financial Report as of March 31, 2013 -- we get the following information about the ongoing litigation involving the drospirenone-containing (DRSP) birth control pills YAZ, Yasmin, Beyaz, Safyral, Gianvi, and Ocella:
Yasmin™ / YAZ™: As of April 15, 2013, the number of lawsuits pending in the United States and served upon Bayer was about 10,200. In addition, about 1,340 asserted claims were pending that have not been filed in court....
As of April 15, 2013, Bayer had reached agreements, without admission of liability, to settle the claims of approximately 5,700 claimants in the U.S. for a total amount of about US$1.18 billion. Bayer has only been settling claims in the U.S. for venous clot injuries (deep vein thrombosis [DVT] or pulmonary embolism [PE]).... Such injuries are alleged by about 2,900 of the pending unsettled claimants.... Bayer will continue to consider the option of settling such individual lawsuits in the U.S. on a case-by-case basis.
Free Case Evaluation
Strictly Confidential, No Obligation.
From reading this "new" DRSP birth control litigation information from Bayer in conjunction with our last update, "As Bayer Settlements For YAZ, Yasmin, Ocella, And Gianvi Continue In 2013, Total Payments Will Go Over The $1 Billion Level -- According To Bayer 2012 Annual Report, More Than 3200 Blood Clot Claims Remain Unsettled And Additional Lawsuits Are Anticipated By Drug Company", one can see that, while Bayer has paid out more money in settlements, it has also been sued by more women who have developed a DVT and/or PE while using these controversial birth control pills.
We will continue to monitor the YAZ / Yasmin / Ocella litigation and provide addtional periodic updates on the number of lawsuits and settlements by Bayer.______________________________________________________________________________